REN RELX Plc

   By Adria Calatayud 
 

RELX PLC (REL.LN) said Thursday that 2018 net profit fell 14% as the company booked a lower gain from U.S. tax credits, and it launched a smaller buyback than in prior years after increasing acquisition spending.

The information-and-analytics company said it plans to buy back shares worth 600 million pounds ($783.1 million) this year, having completed annual share-repurchase programs of GBP700 million over the last three years.

In 2018, the company behind medical journal the Lancet and the London Book Fair made a net profit of GBP1.42 billion, or 71.9 pence a share, compared with GBP1.65 billion a year before, or 81.6 pence a share, it said.

Adjusted operating profit--excluding acquisitions and disposals and other exceptional items--rose 6% on an underlying basis to GBP2.35 billion in 2018, RELX said. Adjusted earnings per share increased 7% at constant currency to 84.7 pence, the company said.

Analysts expected an adjusted EPS of 84.4 pence, according to a consensus provided by the company based on estimates by 17 analysts.

RELX's underlying revenue grew 4% last year, the company said. Revenue totaled GBP7.49 billion last year, up 2% from GBP7.34 billion in 2017, RELX said.

The company last year simplified its corporate structure into a single-parent structure and bought U.S. authentication company ThreatMetrix for GBP580 million.

For 2019, RELX said it expects another year of underlying growth in revenue and in adjusted operating profit, together with growth in adjusted earnings per share on a constant currency basis.

Write to Adria Calatayud at adria.calatayudvaello@dowjones.com

(END) Dow Jones Newswires

February 21, 2019 02:41 ET (07:41 GMT)

RELX (EU:REN)
Historical Stock Chart
From Mar 2024 to Apr 2024

RELX (EU:REN)
Historical Stock Chart
From Apr 2023 to Apr 2024